Intra-Cellular Therapies to Host Second Quarter 2020 Financial Results Conference Call and Webcast
August 04 2020 - 8:00AM
Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical
company focused on the development of and commercialization of
therapeutics for central nervous system (CNS) disorders, today
announced that it will host a conference call and live webcast
discussion at 8:30 a.m. Eastern Time on Monday, August 10, 2020, to
provide a corporate update and discuss details of the Company's
financial results for the quarter ended June 30, 2020.
To access the live conference call via phone, dial 1-(844)
835-6563. The international dial-in number is 1-(970) 315-3916. The
conference ID number for the live call is 1574586.
The live and archived webcast can be accessed under "Events
& Presentations" in the Investor Relations section of the
Company's website at www.intracellulartherapies.com. Please log in
approximately 5-10 minutes prior to the event to register and to
download and install any necessary software.
About Intra-Cellular Therapies
Intra-Cellular Therapies is a biopharmaceutical company founded
on Nobel prize-winning research that allows us to understand how
therapies affect the inner-workings of cells in the body. The
company leverages this intracellular approach to develop innovative
treatments for people living with complex psychiatric and
neurologic diseases. For more information, please visit
www.intracellulartherapies.com.
CONTACT:
Intra-Cellular Therapies, Inc. Juan Sanchez, M.D. Vice
President, Corporate Communications and Investor Relations
646-440-9333
Burns McClellan, Inc. Lisa Burns jgrimaldi@burnsmc.com
212-213-0006
Intra Cellular Therapies (NASDAQ:ITCI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Intra Cellular Therapies (NASDAQ:ITCI)
Historical Stock Chart
From Apr 2023 to Apr 2024